Taste Properties of HIV Inhibitor

An Open-Label Taste Assessment of BMS-955176 in Healthy Subjects

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02608918

Enrollment

Registered

2015-11-20

Start date

2016-01-05

Completion date

2016-05-24

Last updated

2018-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections

Brief summary

The purpose of the study is to assess the taste properties of HIV inhibitor

Interventions

DRUGBMS-955176

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

OTHER

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

25 Years to 80 Years

Healthy volunteers

Yes

Inclusion criteria

For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com Inclusion Criteria: * Men and women of non-childbearing potential professional sensory panelists * Aged between 25 and 80 years

Exclusion criteria

* History of relevant drug or food allergies, cardiovascular or Central nervous system (CNS) disease, clinically significant pathology, history of mental illness * Positive HIV test

Design outcomes

Primary

Measure	Time frame
Taste properties of HIV Inhibitor will be measured using the Flavor Profile of the Flavor Leadership Criteria	Up to 2 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026